AwardedSpainGoods
Suministro del medicamento QARZIBA 20 mg/4,5 ml (Dinutuximab Beta 20 mg/4,5 ml vial)
- Published
- Published 11 July 2025
Overview
Suministro del principio activo QARZIBA 20 mg/4,5ml (Dinutuximab beta 20 mg/4,5 ml vial) con destino el Servicio de farmacia delHospital Universitario Nuestra Señora de Candelaria, mediante procedimiento negociado sin publicidad y sin concurrencia deofertas.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 11 July 2025
Various medicinal products
Award outcome
- Awarded value
- €493,141
- Award date
- 10 June 2025
- RECORDATI RARE DISEASES SPAIN, SLU
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
11 July 2025
Contracting authority
Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria
Procuring entitySanta Cruz de Tenerife, Spain
ID_PLATAFORMA: 31087770152537
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.